Crosstalk among long non-coding RNA, tumor-associated macrophages and small extracellular vesicles in tumorigenesis and dissemination
- PMID: 36263199
- PMCID: PMC9574020
- DOI: 10.3389/fonc.2022.1008856
Crosstalk among long non-coding RNA, tumor-associated macrophages and small extracellular vesicles in tumorigenesis and dissemination
Abstract
Long noncoding RNAs (lncRNAs), which lack protein-coding ability, can regulate cancer cell growth, proliferation, invasion, and metastasis. Tumor-associated macrophages (TAMs) are key components of the tumor microenvironment that have a significant impact on cancer progression. Small extracellular vesicles (sEV) are crucial mediators of intercellular communications. Cancer cell and macrophage-derived sEV can carry lncRNAs that influence the onset and progression of cancer. Dysregulation of lncRNAs, TAMs, and sEV is widely observed in tumors which makes them valuable targets for cancer immunotherapy. In this review, we summarize current updates on the interactions among sEV, lncRNAs, and TAMs in tumors and provide new perspectives on cancer diagnosis and treatment.
Keywords: TAMs; lncRNA; sEV; tumor microenvironment; tumorigenesis.
Copyright © 2022 Zhang, Chen, Liang, Ponnusamy, Qin and Lin.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Turning adversity into opportunity: Small extracellular vesicles as nanocarriers for tumor-associated macrophages re-education.Bioeng Transl Med. 2022 Jun 9;8(1):e10349. doi: 10.1002/btm2.10349. eCollection 2023 Jan. Bioeng Transl Med. 2022. PMID: 36684102 Free PMC article. Review.
-
Crosstalk Among YAP, LncRNA, and Tumor-Associated Macrophages in Tumorigenesis Development.Front Oncol. 2022 Jan 6;11:810893. doi: 10.3389/fonc.2021.810893. eCollection 2021. Front Oncol. 2022. PMID: 35071016 Free PMC article. Review.
-
Macrophage lncRNAs in cancer development: Long-awaited therapeutic targets.Biochem Pharmacol. 2023 Dec;218:115890. doi: 10.1016/j.bcp.2023.115890. Epub 2023 Oct 24. Biochem Pharmacol. 2023. PMID: 37884197 Review.
-
Exosome derived from tumor-associated macrophages: biogenesis, functions, and therapeutic implications in human cancers.Biomark Res. 2023 Nov 19;11(1):100. doi: 10.1186/s40364-023-00538-w. Biomark Res. 2023. PMID: 37981718 Free PMC article. Review.
-
The multifaceted roles of small extracellular vesicles in metabolic reprogramming in the tumor microenvironments.Proteomics. 2024 Jun;24(11):e2300021. doi: 10.1002/pmic.202300021. Epub 2024 Jan 3. Proteomics. 2024. PMID: 38171844 Review.
Cited by
-
Exosome-mediated communication between gastric cancer cells and macrophages: implications for tumor microenvironment.Front Immunol. 2024 Feb 22;15:1327281. doi: 10.3389/fimmu.2024.1327281. eCollection 2024. Front Immunol. 2024. PMID: 38455041 Free PMC article. Review.
-
Macrophage-derived lncRNAs in cancer: regulators of tumor progression and therapeutic targets.Med Oncol. 2025 Mar 6;42(4):91. doi: 10.1007/s12032-025-02643-2. Med Oncol. 2025. PMID: 40048034 Review.
-
LncRNA HAGLROS promotes breast cancer evolution through miR-135b-3p/COL10A1 axis and exosome-mediated macrophage M2 polarization.Cell Death Dis. 2024 Aug 28;15(8):633. doi: 10.1038/s41419-024-07020-x. Cell Death Dis. 2024. PMID: 39198393 Free PMC article.
-
Mitochondrial transplantation as a novel therapeutic strategy for cardiovascular diseases.J Transl Med. 2023 May 25;21(1):347. doi: 10.1186/s12967-023-04203-6. J Transl Med. 2023. PMID: 37231493 Free PMC article. Review.
-
Complicated crosstalk between HMGA and non-coding RNAs modulates hallmarks of cancer.Cancer Cell Int. 2025 Mar 7;25(1):80. doi: 10.1186/s12935-025-03713-1. Cancer Cell Int. 2025. PMID: 40055693 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources